// App-Quantinova.ai

e19321 : MET status and treatment outcomes in papillary renal cell carcinoma (PRCC): Pooled analysis of historical data.

Researchers

Presenter

  • Laurence Albiges

Principal Investigators

  • Daniel Yick Chin Heng

  • Jae-Lyun Lee

  • Stephen Walker

  • Anders Mellemgaard

  • Lone Ottesen

  • Melanie M. Frigault

  • Anne L'Hernault

  • Jonathan Wessen

  • Toni K. Choueiri

  • Mathilde Cancel

  • Sabina Signoretti

Medical Centers

  • Department of Cancer Medicine, Institut Gustave Roussy, Paris-Sud University, Villejuif, France

  • Department of Radiation Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada

  • Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

  • Oncology R&D, AstraZeneca, Boston, MA

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • Hopital Bretonneau, Tours, France

  • Department of Medicine, Brigham and Women's Hospital, Boston, MA

Locations

  • France

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Hepatocyte growth factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved